Oncimmune has sold a substantial interest in its US subsidiary business, including its CLIA certified laboratory, to Health Diagnostics Laboratory (HDL).  Oncimmune is an industry leader in early cancer detection.  In 2009, Oncimmune launched its proprietary platform technology for early cancer … Continue reading →